R
Ryan D. Kilpatrick
Researcher at AbbVie
Publications - 52
Citations - 4949
Ryan D. Kilpatrick is an academic researcher from AbbVie. The author has contributed to research in topics: Population & Hazard ratio. The author has an hindex of 23, co-authored 47 publications receiving 4578 citations. Previous affiliations of Ryan D. Kilpatrick include University of California, Los Angeles & Los Angeles Biomedical Research Institute.
Papers
More filters
Journal ArticleDOI
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
Kamyar Kalantar-Zadeh,Kamyar Kalantar-Zadeh,N. Kuwae,Deborah L. Regidor,Deborah L. Regidor,Csaba P. Kovesdy,Ryan D. Kilpatrick,Ryan D. Kilpatrick,Christian S. Shinaberger,Christian S. Shinaberger,Charles J. McAllister,Matthew J. Budoff,Isidro B. Salusky,Isidro B. Salusky,Joel D. Kopple,Joel D. Kopple +15 more
TL;DR: Associations between high serum parathyroid hormone and increased death risk were masked by case-mix characteristics of MHD patients, and Administration of any dose of paricalcitol was associated with improved survival in time-varying models.
Journal ArticleDOI
Survival advantages of obesity in dialysis patients
Kamyar Kalantar-Zadeh,Kevin C. Abbott,Abdulla K Salahudeen,Ryan D. Kilpatrick,Tamara B. Horwich +4 more
TL;DR: The causes and consequences of the reverse epidemiology of obesity in dialysis patients can enhance insights into similar paradoxes observed for other conventional risk factors, such as blood pressure and serum cholesterol and homocysteine concentrations, and in other populations such as those with CHF, advanced age, cancer, or AIDS.
Journal ArticleDOI
Associations Between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients
Deborah L. Regidor,Joel D. Kopple,Csaba P. Kovesdy,Ryan D. Kilpatrick,Charles J. McAllister,Jason Aronovitz,Sander Greenland,Kamyar Kalantar-Zadeh +7 more
TL;DR: In this article, longitudinal associations between survival and quarterly (13-wk averaged) hemoglobin values and administered erythropoiesis-stimulating agents (ESA) dose in a 2-yr (July 2001 to June 2003) cohort of 58,058 maintenance hemodialysis patients from a large dialysis organization (DaVita) in the United States.
Journal ArticleDOI
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction
Kamyar Kalantar-Zadeh,Ryan D. Kilpatrick,Noriko Kuwae,Charles J. McAllister,Harry Alcorn,Joel D. Kopple,Sander Greenland +6 more
TL;DR: Time-varying hypoalbuminaemia predicts all-cause and CV death differently from fixed measures of serum albumin in MHD patients, and an increase in serumalbumin over time is associated with better survival independent of baseline serum albumIn or other MICS surrogates.
Journal ArticleDOI
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.
Kamyar Kalantar-Zadeh,Joel D. Kopple,Ryan D. Kilpatrick,Charles J. McAllister,Christian S. Shinaberger,David W. Gjertson,Sander Greenland +6 more
TL;DR: Weight gain and both baseline and time-varying obesity may be associated with reduced cardiovascular mortality in MHD patients independent of laboratory surrogates of nutritional status and their changes over time.